-+ 0.00%
-+ 0.00%
-+ 0.00%

Castle Biosciences CEO Derek Maetzold disposes of common shares worth $129,609.50

PUBT·06/03/2026 20:16:51
Listen to the news
Castle Biosciences CEO Derek Maetzold disposes of common shares worth $129,609.50
  • Castle Biosciences CEO Derek J. Maetzold sold 6,214 shares on June 1 at USD 20.86, cutting direct holdings to 21,479 shares.
  • He exercised options for 6,214 shares at USD 2.39 on the same day.
  • Sales also occurred across trusts tied to Maetzold, including 1,357 shares from the Maetzold Descendants 2020 Trust.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Castle Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-040260), on June 03, 2026, and is solely responsible for the information contained therein.